How Much Did Blackrock Neurotech Raise?
Funding & Key Investors

Blackrock Neurotech has secured $10M in a major strategic investment, contributing to its overall $10M in enterprise-level funding. This significant capital infusion underscores the company's pivotal role in advancing neurotechnology and its potential for transformative impact in the medical device sector.

What is Blackrock Neurotech?

Blackrock Neurotech
ManufacturingMedical Devices & EquipmentBusiness Services

Blackrock Neurotech is dedicated to developing innovative tools and expertise in neurotechnology, aiming to translate cutting-edge research into implantable clinical solutions that enhance human lives. At the heart of its offerings is precision electrode technology, a foundational element for numerous global advancements in Brain-Computer Interfaces (BCI). Through sophisticated neural signal processing and stimulation, Blackrock Neurotech's innovations have empowered individuals with severe neurological impairments to regain critical functions such as walking, talking, seeing, hearing, and feeling.

How much funding has Blackrock Neurotech raised?

Blackrock Neurotech has raised a total of $10M across 1 funding round:

2021

Unspecified

$10M

Unspecified (2021): $10M with participation from re.Mind Capital and Sorenson Impact.png

Key Investors in Blackrock Neurotech

re.Mind Capital

re.Mind Capital is an investor participating in the funding round, with a focus likely aligned with neurotechnology and mental wellness advancements.

Sorenson Impact.png

Sorenson Impact Group is a multidisciplinary investment platform focused on aligning mission and values with capital, specializing in innovative investment opportunities that deliver market-rate returns while addressing social and environmental challenges. Their involvement suggests a strategic alignment with Blackrock Neurotech's mission-driven approach to improving human lives through technology.

What's next for Blackrock Neurotech?

With this recent major strategic investment, Blackrock Neurotech is poised to accelerate its development and deployment of advanced neurotech solutions. The company's focus on translating technology into clinical applications suggests a trajectory towards scaling its BCI technologies for broader patient access. Future growth will likely involve further research and development, strategic partnerships, and regulatory approvals to bring its life-changing innovations to market, solidifying its position as a leader in the neurotechnology landscape.

See full Blackrock Neurotech company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Chemicals & Related ProductsManufacturingBuilding MaterialsPlastic, Packaging & Containers
ManufacturingTextiles & Apparel
Industrial Machinery & EquipmentManufacturing
ManufacturingWatches & JewelryRetailJewelry & Watch Retail

Frequently Asked Questions Regarding Blackrock Neurotech Financial Insights

What are the most recent funding rounds that Blackrock Neurotech has completed, and what were the funding rounds?
Blackrock Neurotech has recently completed 1 funding rounds: Unspecified on May 19, 2021.
What is the total amount of funding Blackrock Neurotech has raised to date?
Blackrock Neurotech has raised a total of $10M in funding to date.
How many funding rounds has Blackrock Neurotech completed?
Blackrock Neurotech has completed 1 funding rounds.
How much funding did Blackrock Neurotech raise in its most recent funding round?
Blackrock Neurotech raised $10M in its most recent funding round.
Who are the lead investors in Blackrock Neurotech's latest funding round?
The lead investor in Blackrock Neurotech's latest funding round was re.Mind Capital. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Blackrock Neurotech's history?
The largest funding round in Blackrock Neurotech's history was $10M.
See more information about Blackrock Neurotech